Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.66 |
| ▸ | MAPT | P10636 | 3/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | DGKA | P23743 | 1/20 | 0.53 |
| ▸ | PRKCA | P17252 | 1/20 | 0.53 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.53 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.53 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | GMNN | O75496 | 1/20 | 0.49 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9954995 | 1.00 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1DGKA | |
| SCHEMBL9956274 | 1.00 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1DGKA | |
| SCHEMBL9955334 | 1.00 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1DGKA | |
| SCHEMBL29391454 | 1.00 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1DGKA | |
| SCHEMBL9954244 | 1.00 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1DGKA | |
| SCHEMBL17812617 | 1.00 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1DGKA | |
| SCHEMBL3814948 | 1.00 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1DGKA | |
| SCHEMBL9953958 | 1.00 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1DGKA | |
| SCHEMBL9954412 | 1.00 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1DGKA | |
| SCHEMBL9955722 | 0.94 | LMNA (0.68) | LMNAMAPTMAPK1ALDH1A1DGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119868207-A | Efficient makeup-holding foundation liquid and preparation method thereof | 广州奥蓓斯化妆品有限公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-113164357-B | Use of polycarboxylic acid compounds for treating fibrous substrates based on amino acids, in particular hair | 迈图高新材料公司 | 2024-12-10 | — | — | CN | disclosed |
| CN-118900681-A | Sun-screening agent containing disodium phenylbisbenzimidazole tetrasulfonate, troxerutin and disodium terephthalylidene-camphorsulfonate | 拜尔斯道夫股份有限公司 | 2024-11-05 | — | — | CN | disclosed |
| CN-117295482-A | Emulsified or oil-dispersed cosmetic composition comprising high levels of powder | 株式会社LG生活健康 | 2023-12-26 | — | — | CN | disclosed |
| US-20230340435-A1 | BASE EDITING OF ANGPTL3 AND METHODS OF USING SAME FOR TREATMENT OF DISEASE | VERVE THERAPEUTICS, INC. | 2023-10-26 | — | — | US | disclosed |
| US-20230340435-A1 | BASE EDITING OF ANGPTL3 AND METHODS OF USING SAME FOR TREATMENT OF DISEASE | VERVE THERAPEUTICS, INC. | 2023-10-26 | — | — | US | disclosed |
| CN-116113659-A | Non-isocyanate polyurethane elastomer and composition containing the same | 纳米技术有限责任公司(以生物科学博士名义) | 2023-05-12 | — | — | CN | disclosed |
| US-9655934-B2 | Dermatologically effective yeast extract | EVONIK DEGUSSA GMBH (DE) | 2017-05-23 | — | — | US | disclosed |
| US-20140127257-A1 | DERMATOLOGICALLY EFFECTIVE YEAST EXTRACT | EVONIK DEGUSSA GMBH (DE) | 2014-05-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230340435-A1 | BASE EDITING OF ANGPTL3 AND METHODS OF USING SAME FOR TREATMENT OF DISEASE | LDLR, PCSK9, APOB | LMNA 145/4885MAPT 4473/4885MAPK1 4862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.